To evaluate the long-term efficacy and safety of infliximab in patients with Behçet's disease (BD) and refractory bilateral posterior uveitis, and to assess the proportion of relapse-free subjects through months 12 and 24.
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study / Niccoli, L; Nannini, C; Benucci, M; Chindamo, D; Cassarà, E; Salvarani, Carlo; Cimino, L; Gini, G; Lenzetti, I; Cantini, F.. - In: RHEUMATOLOGY. - ISSN 1462-0324. - 46:7(2007), pp. 1161-1164. [10.1093/rheumatology/kem101]
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study
SALVARANI, CARLO;Cimino, L;
2007
Abstract
To evaluate the long-term efficacy and safety of infliximab in patients with Behçet's disease (BD) and refractory bilateral posterior uveitis, and to assess the proportion of relapse-free subjects through months 12 and 24.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
